» Articles » PMID: 37829610

Revealing a Causal Relationship Between Gut Microbiota and Lung Cancer: a Mendelian Randomization Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The gut microbiota has been found to be associated with the risk of lung cancer. However, its causal relationship with various types of lung cancer remains unclear.

Methods: We conducted a Mendelian randomization (MR) study using the largest genome-wide association analysis of gut microbiota data to date from the MiBioGen consortium, with pooled statistics for various types of lung cancer from the Transdisciplinary Research in Cancer of the Lung, the International Lung Cancer Consortium, and FinnGen Consortium R7 release data. Inverse variance weighted, weighted model, MR-Egger regression, and weighted median were adapted to assess the causal relationship between gut microbiota and various types of lung cancer. Sensitivity analysis was used to test for the presence of pleiotropy and heterogeneity in instrumental variables. A reverse MR analysis was performed on these bacteria to determine their potential role in causing lung cancer. A reverse MR analysis was performed on these bacteria to determine their potential role in causing lung cancer. Multivariable Mendelian randomization (MVMR) was conducted to assess the direct causal impact of gut microbiota on the risk of various types of lung cancer.

Results: Using IVW as the primary analytical method, we identified a total of 40 groups of gut microbiota with potential causal associations with various subtypes of lung cancer, of which 10 were associated with lung cancer, 10 with lung adenocarcinoma, 9 with squamous cell lung cancer, and 11 groups of bacteria associated with small cell lung cancer. After performing FDR correction, we further found that there was still a significant causal relationship between Peptococcaceae and lung adenocarcinoma. Sensitivity analyses demonstrated the robustness of these results, with no heterogeneity or pleiotropy found.

Conclusions: Our results confirm a causal relationship between specific gut microbiota and lung cancer, providing new insights into the role of gut microbiota in mediating the development of lung cancer.

Citing Articles

Causal relationship between circulating immune cells and the risk of esophageal cancer: a Mendelian randomization study.

Wang S, Wang R, Zhang A, Duan X, Shang X, Jiang H Discov Oncol. 2025; 16(1):220.

PMID: 39982541 PMC: 11845655. DOI: 10.1007/s12672-025-01921-9.


Plant-based diets and the risk of lung cancer: a large prospective cohort study.

Wei W, Wang S, Yuan Z, Ren Y, Wu J, Gao X Eur J Nutr. 2025; 64(2):73.

PMID: 39891747 PMC: 11787154. DOI: 10.1007/s00394-024-03570-0.


Impact of Ketogenic and Mediterranean Diets on Gut Microbiota Profile and Clinical Outcomes in Drug-Naïve Patients with Diabesity: A 12-Month Pilot Study.

Palmas V, Deledda A, Heidrich V, Sanna G, Cambarau G, Fosci M Metabolites. 2025; 15(1).

PMID: 39852366 PMC: 11766981. DOI: 10.3390/metabo15010022.


The Intriguing Connection Between the Gut and Lung Microbiomes.

Druszczynska M, Sadowska B, Kulesza J, Gasienica-Gliwa N, Kulesza E, Fol M Pathogens. 2024; 13(11).

PMID: 39599558 PMC: 11597816. DOI: 10.3390/pathogens13111005.


The causal relationship between gut microbiota and 2 neoplasms, malignant and benign neoplasms of bone and articular cartilage: A two-sample Mendelian randomization study.

Lv J, Qin X, Wang J, Li J, Bai J, Lan Y Medicine (Baltimore). 2024; 103(46):e40519.

PMID: 39560555 PMC: 11576038. DOI: 10.1097/MD.0000000000040519.


References
1.
Li P, Wang H, Guo L, Gou X, Chen G, Lin D . Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study. BMC Med. 2022; 20(1):443. PMC: 9667679. DOI: 10.1186/s12916-022-02657-x. View

2.
Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A . Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021; 53(2):156-165. PMC: 8515199. DOI: 10.1038/s41588-020-00763-1. View

3.
Hao S, Li S, Wang J, Zhao L, Yan Y, Cao Q . Transcriptome Analysis of Phycocyanin-Mediated Inhibitory Functions on Non-Small Cell Lung Cancer A549 Cell Growth. Mar Drugs. 2018; 16(12). PMC: 6316159. DOI: 10.3390/md16120511. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Xu Q, Ni J, Han B, Yan S, Wei X, Feng G . Causal Relationship Between Gut Microbiota and Autoimmune Diseases: A Two-Sample Mendelian Randomization Study. Front Immunol. 2022; 12:746998. PMC: 8819003. DOI: 10.3389/fimmu.2021.746998. View